The Malaria vaccine has been reported to be near to success amid thousands of cases. A study is reported that researchers have found out that the parasite's proteins could be effective in defeating one of the world’s deadliest disease.
According to Daily News, an investigation has found out that some insecticide prone insects are becoming difficult to control as the Health ministry on Goromonzi, Mashonaland East stated. It was shared that the drastic case of malaria in the country has already risen up to 154 in just a week starting March 26, 2017.
Fortunately, it was recently reported that a breakthrough for discovering an effective vaccine against malaria is already being investigated further. Phys then reported that Professor Tania de Koning-Ward and her team of researchers from Deakin's Centre for Molecular and Medical Research found out an effective way to kill malaria once and for all.
"Malaria parasites live inside the host's red blood cells. They produce a group of proteins to change the permeability of the red blood cell, making it more porous, so they can absorb from the plasma the vital nutrients they need to survive and replicate, as well as remove toxic waste products," de Koning-Ward explained.
Hence, it was mentioned that blocking the aforementioned malaria parasite’s proteins would lead to the parasite starving to death amid it being in the blood. However, the investigation results were still in process to become a vaccine compared to a Queensland study that is already halfway through.
ABC then identified that the advanced Queensland study was led by the Gold Coast University Hospital and Griffith University. Griffith University Institute for Glycomics researcher Michael Good was one of the volunteers in the trial.
He then identified their unusual approach that led to the conclusion of the study. "It involves the entire malaria parasite, which we effectively put to sleep with a drug which binds to its DNA," Good shared.
Nonetheless, the researchers aim to test the study on 20 to 30 people more so that they could use the vaccine on people in Uganda. The study authors then hoped that a vaccine from the investigation would become available within 5-10 years from now.
